Costas, Inc. Stock Price - CSSI

Best deals to access real time data!
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Ultimate Trader
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Costas, Inc. (PL) CSSI OTCMarkets Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0104 -20.12% 0.0413 0.0525 0.0413 0.0525 0.0517 15:14:45
Bid Price Ask Price Spread Spread % News
0.0413 0.0599 0.0186 31.05% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 65,640 $ 0.041599 $ 2,731 20,997 0.013 - 0.22
Last Trade Time Type Quantity Stock Price Currency
15:14:45 45,639 $ 0.0413 USD

Costas, Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 1.79M 43.31M - - 10.43M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
10.00k $ - 0.00% - -

more financials information »

Costas, Inc. News

Loading Messages....

Latest CSSI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CSSI Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.05170.05250.04130.051715k-0.0104-20.12%
1 Month0.060.0750.04130.060714k-0.0187-31.17%
3 Months0.060.07990.040.055531k-0.0187-31.17%
6 Months0.0850.160.040.097742k-0.0437-51.41%
1 Year0.01610.220.0130.103777k0.0252156.52%
3 Years0.10.58990.0020.1408105k-0.0587-58.70%
5 Years0.03120.0020.143586k0.010333.23%

Costas, Inc. Description

Costas, soon to be known as Atlas Nanotech is a company that works on research, development and patenting of nanotechnology applied to medicine. The products of Atlas Nanotech aim to the prevention of disease and to imaging, diagnosis, monitoring, treatment, repair, and regeneration the human body. Total nanomedicine sales were $78 billion in 2012 and are projected to reach $1 trillion in 2022. The new executives of Costas are heavily invested in nanomedicine with time, education and finances, and have built a large pipeline of marketable products".

Your Recent History
Costas, In..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.